Viridius Limited is a biotechnology company specializing in the integration of biotechnology and nanotechnology to deliver innovative healthcare solutions. Our mission is to translate frontier scientific research into clinical applications that are safe, effective, and accessible. Our research focuses on semi-invasive therapeutic approaches, with a core platform built on piezocatalysis technology. This method harnesses the unique properties of nanomaterials activated by ultrasound, creating new possibilities for treating prevalent cholesterol-related conditions.

By combining interdisciplinary expertise with strong translational research capacity, Viridius is advancing novel technologies from laboratory discovery toward clinical impact, aiming to improve patient outcomes and support sustainable healthcare development.